Trials / Completed
CompletedNCT02802241
Effects of Open-label vs Double-blind Treatment in IBS
Effects of Open-label vs Double-blind Treatment in IBS.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 340 (actual)
- Sponsor
- Beth Israel Deaconess Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate placebo effects and peppermint oil in Irritable Bowel Syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | placebo | |
| DIETARY_SUPPLEMENT | peppermint oil |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2019-01-01
- Completion
- 2019-01-01
- First posted
- 2016-06-16
- Last updated
- 2024-01-22
- Results posted
- 2020-09-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02802241. Inclusion in this directory is not an endorsement.